Röjdmark J, Järhult J
Department of Surgery, Eksjö Hospital, Sweden.
Eur J Surg. 1995 Oct;161(10):725-7.
To establish the long term recurrence rate in patients operated on for nodular goitre and to find out if oral treatment with thyroxine reduces this risk.
Retrospective study.
District hospital, Sweden.
43 patients who underwent subtotal thyroidectomy for nodular goitre (36 non-toxic, 7 toxic) from 1960-65, and who were re-examined in 1993; 11 patients were given oral thyroxine during the postoperative period and the remaining 32 had no medical treatment.
Recurrence of goitre.
5/11 goitres recurred in the thyroxine group (45%) and 13/32 (41%) in the untreated group.
The recurrence rate of nodular goitre is high 30 years after subtotal thyroidectomy. Long term oral thyroxine does not seem to change the picture.
确定接受结节性甲状腺肿手术患者的长期复发率,并探究甲状腺素口服治疗是否能降低这种风险。
回顾性研究。
瑞典地区医院。
1960年至1965年间因结节性甲状腺肿接受甲状腺次全切除术的43例患者(36例为非毒性,7例为毒性),并于1993年进行复查;11例患者在术后接受甲状腺素口服治疗,其余32例未接受药物治疗。
甲状腺肿复发情况。
甲状腺素组11例中有5例复发(45%),未治疗组32例中有13例复发(41%)。
甲状腺次全切除术后30年,结节性甲状腺肿的复发率很高。长期口服甲状腺素似乎并未改变这一情况。